Volume 54, Pages S135-S139 (December 1998)

Slides:



Advertisements
Similar presentations
A.M. Thompson, T.G. Pickering  Kidney International 
Advertisements

Plasma sodium and hypertension
Renal manifestations in Fabry disease and therapeutic options
Volume 58, Issue 1, Pages (July 2000)
Epidemiology of diabetic nephropathy in Spain
Volume 75, Issue 3, Pages (February 2009)
Volume 54, Pages S86-S91 (December 1998)
Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani 
Volume 63, Pages S32-S38 (June 2003)
Progression of renal failure and hypertensive nephrosclerosis
Volume 70, Pages S21-S25 (December 2006)
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients  Tatsuya Shoji, Yoshiharu Tsubakihara,
S.G. John, N.M. Selby, C.W. McIntyre  Kidney International 
Volume 76, Issue 3, Pages (August 2009)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
A new era in phosphate binder therapy: What are the options?
Volume 81, Issue 3, Pages (February 2012)
Volume 70, Issue 11, Pages (December 2006)
The epidemiology of chronic kidney disease
Volume 91, Issue 5, Pages (May 2017)
Prevention of renal failure: The Malaysian experience
Volume 74, Issue 9, Pages (November 2008)
Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1  Lyndsay S. Baines, John T. Joseph,
Volume 70, Issue 12, Pages (December 2006)
Volume 67, Pages S48-S51 (January 2005)
Blood pressure targets in hemodialysis patients
Volume 72, Issue 12, Pages (December 2007)
Recent experience with high-dose intravenous iron administration
Volume 58, Issue 1, Pages (July 2000)
Volume 61, Issue 6, Pages (June 2002)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Proteinuria and hypertensive nephrosclerosis in African Americans
Non-immunologic intervention in chronic allograft nephropathy
Nephrology in Latin America, with special emphasis on Brazil
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
The kidney, a cardiovascular risk marker, and a new target for therapy
Counteracting progression of renal disease: A look into the future
Neurogenic factors and hypertension in renal disease
Measurement of renal function in pre-ESRD patients
Volume 76, Issue 12, Pages (December 2009)
Volume 81, Issue 4, Pages (February 2012)
Volume 54, Pages S135-S139 (December 1998)
Circadian regulation of renal function
Volume 62, Pages S47-S52 (December 2002)
Homocysteine, renal function, and risk of cardiovascular disease
Volume 64, Issue 2, Pages (August 2003)
Long-term survival in renal transplant recipients with graft function
The course of the remnant kidney model in mice
Clinical benefits of slowing the progression of renal failure
Organ transplantation goes to the movies
Volume 55, Pages S3-S16 (June 1999)
Volume 63, Issue 6, Pages (June 2003)
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney.
Is it the low-protein diet or simply the salt restriction?
Charles A. Herzog  Kidney International 
Volume 62, Pages S36-S41 (December 2002)
Renal replacement therapy in Latin America
Importance of blood pressure control in hemodialysis patient survival
Volume 70, Issue 5, Pages (September 2006)
The international realities of live donor kidney transplantation
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Renal vascular disease in the elderly
Volume 55, Pages S41-S46 (June 1999)
Volume 73, Issue 11, Pages (June 2008)
Kidney and hypertension
Volume 57, Pages S44-S48 (April 2000)
Ronen Levi, Justin Silver  Kidney International 
Antonio Piccoli, Luana Pillon  Kidney International 
Presentation transcript:

Volume 54, Pages S135-S139 (December 1998) Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients  Domingo del Castillo, José María Campistol, Luis Guirado, Luis Capdevilla, Javier G. Martínez, Porfirio Pereira, Juan Bravo, Rodrigo Pérez  Kidney International  Volume 54, Pages S135-S139 (December 1998) DOI: 10.1046/j.1523-1755.1998.06827.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Mean change from baseline in diastolic (DBP) and systolic (SBP) blood pressure at weeks 4, 8, 12 (*P < 0.001). Kidney International 1998 54, S135-S139DOI: (10.1046/j.1523-1755.1998.06827.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Mean change from baseline in creatinine at weeks 4, 8, 12 (*P < 0.0002; #NS vs. week 8). Kidney International 1998 54, S135-S139DOI: (10.1046/j.1523-1755.1998.06827.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Mean change from baseline in potassium at weeks 4, 8, 12 (P < 0.01; #NS vs. week 4). Kidney International 1998 54, S135-S139DOI: (10.1046/j.1523-1755.1998.06827.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, S135-S139DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, S135-S139DOI: (10.1046/j.1523-1755.1998.06827.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, S135-S139DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, S135-S139DOI: (10.1046/j.1523-1755.1998.06827.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, S135-S139DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, S135-S139DOI: (10.1046/j.1523-1755.1998.06827.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.